Expert Review of Gastroenterology & Hepatology

Papers
(The median citation count of Expert Review of Gastroenterology & Hepatology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Imaging in pediatric disorders of the gut-brain interactions: current best practice and future directions181
Ripretinib for the treatment of adult patients with advanced gastrointestinal stromal tumors79
Prevention of pancreatitis after stent implantation for distal malignant biliary strictures: systematic review and meta-analysis75
COVID-19 and hygiene hypothesis: increment of the inflammatory bowel diseases in next generation?61
A consensus integrated care pathway for patients with primary biliary cholangitis: a guideline-based approach to clinical care of patients51
Differentiated/undifferentiated mixed type is a prognostic factor for T2/T3 gastric cancer patients45
Managing pain in irritable bowel syndrome: current perspectives and best practice30
Gallbladder carcinosarcoma: current perspectives and new development29
Small bowel transplant – novel indications and recent progress26
Irritable bowel syndrome – controversies in diagnosis and management25
Virologic response maintenance and hepatocellular carcinoma in chronic hepatitis B patients treated with entecavir22
A narrative review on the diagnosis and management of constipation in infants21
ERCP-related adverse events: incidence, mechanisms, risk factors, prevention, and management21
The assessment of impaired liver function and prognosis in hepatocellular carcinoma21
Terlipressin in the management of adults with hepatorenal syndrome-acute kidney injury (HRS-AKI)20
Early alpha-fetoprotein response predicts prognosis of immune checkpoint inhibitor and targeted therapy for hepatocellular carcinoma: a systematic review with meta-analysis20
Therapeutic drug monitoring in inflammatory bowel disease: recent developments20
Lipid biomarkers in colorectal cancer, with particular emphasis on exosomes – current status and future inferences18
Recent advances in treating constipation in children18
Elucidating the role of extracellular vesicles in liver injury induced by HIV14
Bayesian analysis and the role of local palliative therapeutics for malignant biliary obstruction14
An insight into Clostridioides difficile-associated diarrhea in Saudi children: diagnosis and treatment14
Biliary diversion in progressive familial intrahepatic cholestasis: a systematic review and meta-analysis14
Targeting liver metabolism: a pathway to cure hepatitis B virus?14
Investigating the correlation between COVID-19 and the progression of chronic liver disease14
Misinterpretation and misapplication of biomarkers in inflammatory bowel disease: how do we avoid this?14
Altered gut microbiota is associated with sleep disturbances in patients with minimal hepatic encephalopathy caused by hepatitis B-related liver cirrhosis14
Risk of selected gastrointestinal toxicities in metastatic renal cell carcinoma patients treated with immuno-TKI combinations: a meta-analysis14
Identification of a ferroptosis-related gene signature for predicting the prognosis of cholangiocarcinoma14
Familial intestinal polyposis and device assisted enteroscopy: where do we stand?14
Small bowel imaging in inflammatory bowel disease: updates for 202314
Managing bile acid diarrhea: aspects of contention13
Emerging data on nivolumab for esophageal squamous cell carcinoma13
Impact of biologic therapies and small molecules on the risk of major adverse cardiovascular events in patients with inflammatory bowel diseases: systematic review and meta-analysis of randomized cont13
Contemporary advances in the endoscopic management of cholangiocarcinoma: a review of accomplished milestones and prospective opportunities13
Characteristic endoscopic findings in Helicobacter pylori diagnosis in clinical practice13
Vitamin B12 deficiency and use of proton pump inhibitors: a systematic review and meta-analysis12
Chronic nausea and vomiting: a diagnostic approach12
Preoperative endoscopic ultrasound-guided biliary drainage for primary drainage in obstructive jaundice12
Research progress in the role of gut microbiota and its metabolites in intrahepatic cholestasis of pregnancy12
Recent updates on treatment options for primary follicular lymphoma of the gastrointestinal tract12
IBD in women of reproductive age: where do novel therapies fit in?11
Percutaneous endoscopic gastrostomy prior to esophagectomy for esophageal cancer – a systematic review and meta-analysis11
Evaluating the role of endoscopic ultrasound in pancreatitis11
Impact of the COVID-19 pandemic on hospitalizations with hepatocellular carcinoma in the United States11
Psychological distress in inflammatory bowel disease11
An update on improving long-term outcomes for patients with chronic pancreatitis post-surgery11
Cost-effectiveness of tislelizumab plus chemotherapy vs chemotherapy as first-line treatment of PD-L1 positive advanced gastric or gastroesophageal junction adenocarcinoma from a Chinese perspective11
Two-dimensional shear wave elastography for sparing endoscopy screening in patients with HBV-related compensated advanced chronic liver disease11
To STRIDE or not to STRIDE: a critique of “treat to target” in ulcerative colitis11
Diagnosing eosinophilic esophagitis in pediatric patients10
Artificial intelligence implementation in pancreaticobiliary endoscopy10
The role and function of CD4+ T cells in hepatic ischemia-reperfusion injury10
Highlights of the drug-induced liver injury literature for 202110
Relief from behind: enemas, the back door enforcement to help treating chronic constipation in adults10
Managing pediatric Crohn’s disease: recent insights10
High platelet count predicts poor prognosis in HCC patients undergoing TACE: a propensity score-matched analysis10
Tenofovir versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma: a systematic review and meta-analysis9
Delivering adjuvant and neoadjuvant treatments in the early stages of hepatocellular carcinoma9
Relationship between pathogenic microorganisms and the occurrence of esophageal carcinoma based on pathological type: a narrative review9
Paraneoplastic syndromes in hepatocellular carcinoma: a review9
Gastroesophageal reflux disease in preterm infants: unmet needs9
Managing complications of chronic pancreatitis: a guide for the gastroenterologist9
Germline testing and genetic counseling in biliary tract cancer: an operative proposal to improve the state of art9
Prognostic biomarkers for cholangiocarcinoma (CCA): state of the art9
Interrupting inflammatory bowel disease therapy: why, who, when and how to consider medication holidays9
Investigation of etiology-specific alterations in the gut microbiota in liver cirrhosis9
Towards a better diagnosis of gastro esophageal reflux disease9
The TL1A inhibitors in IBD: what’s in the pot?8
The efficacy and safety of glucocorticoid for perioperative patients with hepatectomy: a systematic review and meta-analysis8
An update on efficacy and safety comparison of biologics in treatment of inflammatory bowel disease targeting TNF-α, interleukins, leukocyte trafficking, Janus-kinase, and sphingosine-1-phosphate rece8
Cytomegalovirus in ulcerative colitis: an evidence-based approach to diagnosis and treatment8
Cross-regulation between microRNAs and key proteins of signaling pathways in hepatocellular carcinoma8
Highlighting novel targets in immunotherapy for liver cancer8
Development and validation of modified Liaoning score for predicting the prognosis of liver cirrhosis: a retrospective, international multicenter, observational study8
Post-endoscopic submucosal dissection electrocoagulation syndrome: a clinical overview8
Management of disease-related abdominal abscesses in Crohn’s disease8
EUS-guided gastro-enteral anastomosis for the treatment of gastric outlet obstruction: is the end of the enteral stent?8
Updates in interaction of gastroesophageal reflux disease and extragastroesophageal digestive diseases8
Modulating the microbiome in chronic liver diseases – current evidence on the role of fecal microbiota transplantation8
Assessment of efficacy and prognostic factors by Gelfoam for DEB-TACE in unresectable large hepatocellular carcinoma with portal vein tumor thrombus: a multi-center retrospective study7
Acute severe ulcerative colitis: defining the precise moment for colectomy7
Novel fibro-inflammatory biomarkers associated with disease activity in patients with Crohn’s disease7
The association between deprivation and the incidence and survival of patients with hepatocellular carcinoma in the West of Scotland7
Addition of thermal ablation to systemic chemotherapy for the treatment of unresectable intrahepatic cholangiocarcinoma: a propensity score matching analysis7
Effects of probiotics on nonalcoholic fatty liver disease: a systematic review and meta-analysis7
Exploring immunological perturbations between hepatocellular carcinoma risk, inflammation and obesity7
Ivosidenib for the treatment of isocitrate dehydrogenase-1 mutant cholangiocarcinoma7
PSC patient with jaundice – should we ERCP?7
Endoscopic ultrasound-guided pancreatic duct drainage: a comprehensive state of the art review7
Primary biliary cholangitis: primary autoimmune disease or primary secretory defect7
Prioritization in inflammatory bowel disease therapy6
Grayscale ultrasonography findings for characterization of gallbladder wall thickening in non-acute setting: a systematic review and meta-analysis6
Mistakes in managing hepatocellular carcinoma and how to avoid them: a narrative review6
Proton beam therapy in the management of hepatocellular carcinoma6
A critical review of upadacitinib for the treatment of adults with moderately to severely active ulcerative colitis6
Induction and maintenance of healing in erosive esophagitis in the United States6
Histamine-producing bacteria and their role in gastrointestinal disorders6
Nutritional aspects of inflammatory bowel disease6
Analysis of the impact on efficacy of lubiprostone dose reduction to manage adverse events in the treatment of chronic constipation in Japan6
Use of fiber-containing enteral formula in pediatric clinical practice: an expert opinion review6
First-line immune checkpoint inhibitor-based combinations in unresectable hepatocellular carcinoma: current management and future challenges6
2023 update on the clinical management of gastroparesis6
Nosocomial spontaneous bacterial peritonitis is associated with high mortality – a systematic review and meta-analysis6
Periodontal and dental health in inflammatory bowel diseases: a systematic review6
The meaning of R1 resection after endoscopic removal of gastric, duodenal and rectal neuroendocrine tumors6
Noninvasive electrical neuromodulation for gastrointestinal motility disorders6
Significance of nucleologenesis, ribogenesis, and nucleolar proteome in the pathogenesis and recurrence of hepatocellular carcinoma6
Medical management of acute severe ulcerative colitis in the hospitalized patient6
To STRIDE or not to STRIDE: a critique of “treat to target” in Crohn´s disease5
Adenoma detection rate in colonoscopy: how can it be improved?5
The role of immunogenicity in optimizing biological therapies for inflammatory bowel disease5
Chronic liver disease and oxidative stress – a narrative review5
Evaluating the molecular and genetic mechanisms underlying gut motility disorders5
Spleen angiosarcoma: a world review5
How widespread and convenient H. pylori susceptibility testing will result in pharmacological opportunities5
Recent advances in the treatment of gastrointestinal motility disorders in children5
Burden of comorbid anxiety and depression in patients with inflammatory bowel disease: a systematic literature review5
Impact of peptic ulcer bleeding on the in-hospital outcomes of cirrhotic patients with acute gastrointestinal bleeding: an international multicenter study5
Integrating behavioral interventions into a holistic approach to metabolic dysfunction-associated steatotic liver disease5
Influence of metabolic dysfunction-associated fatty liver disease on the prognosis of patients with HBV-related acute-on-chronic liver failure5
Recent developments in the diagnosis of pancreatic neuroendocrine neoplasms5
Securing the diagnosis of HRS-AKI: implications for current therapies5
Etiologic factors for Barrett’s esophagus: toward countermeasures in Asia5
Strengths and limitations of risk stratification tools for patients with upper gastrointestinal bleeding: a narrative review5
Diagnostic yield of endoscopic ultrasound-guided liver biopsy in comparison to percutaneous liver biopsy: a systematic review and meta-analysis4
Cold resection for colorectal polyps: where we are and where we are going?4
Advances in our understanding of the molecular heterogeneity of fatty liver disease: toward informed treatment decision making4
Esophageal lymphocytosis: exploring the knowns and unknowns of this pattern of esophageal injury4
Safety and efficacy of indocyanine green fluorescence imaging-guided radical gastrectomy: a systematic review and meta-analysis4
Practical management of mild-to-moderate ulcerative colitis: an international expert consensus4
Targeting MET amplification in Gastro-oesophageal (GO) malignancies and overcoming MET inhibitor resistance: challenges and opportunities4
Low-grade hepatocellular carcinoma characteristics, a practical nomogram and risk stratification system: a SEER population-based study4
Transjugular intrahepatic portosystemic shunt with or without variceal embolization to prevent variceal rebleeding: an updated meta-analysis4
Filgotinib for moderately to severely active ulcerative colitis4
Combination systemic therapies with immune checkpoint inhibitors in biliary tract cancer: effective but not enough?4
CEUS compared with CECT, MRI, and FDG-PET/CT for diagnosing CRC liver metastases: a diagnostic test accuracy systematic review and meta-analysis4
Clinical efficacy and safety of robot assisted surgery for choledochal cysts excisions: a systematic review and meta-analysis4
Role of vitamin D in ulcerative colitis: an update on basic research and therapeutic applications4
Gastroparesis treatment options metoclopramide and prucalopride: analysis of the FDA Adverse Event Reporting System (FAERS) database4
Dual energy computed tomography in Crohn’s disease: a targeted review4
Impact of preceding noncurative endoscopic submucosal dissection on patients with early gastric cancer who undergo subsequent surgery: a meta-analysis4
Stratification of obesity phenotypes to optimize future therapy (SOPHIA)4
Positioning of tofacitinib in treatment of ulcerative colitis: a global perspective4
Sleeve gastrectomy with transit bipartition: a review of the literature4
A critical review of ozanimod for the treatment of adults with moderately to severely active ulcerative colitis4
Hepatobiliary disease after bone marrow transplant4
Antireflux surgery – choosing the right candidate4
Capsule endoscopy - a non-invasive modality to investigate the GI tract: out with the old and in with the new?4
Statins decrease overall mortality and cancer related mortality but are underutilized in NAFLD: a longitudinal analysis of 12,538 individuals4
Screening for pancreatic cancer has the potential to save lives, but is it practical?4
Endoscopic ultrasonography guided gallbladder drainage: “how and when”4
Comprehensive care of ulcerative colitis: new treatment strategies4
What are the true benefits of robotic pancreaticoduodenectomy for patients with pancreatic cancer?4
Therapeutic effect of ustekinumab on patients with extra-intestinal manifestations of Crohn’s disease4
Advances in target drugs and immunotherapy for biliary tract cancer3
Progressing advanced therapies for inflammatory bowel disease: Current status including dual biologic therapy and discontinuation of biologics3
Anorexia nervosa and gut microbiome: implications for weight change and novel treatments3
The effect of medical cannabis in inflammatory bowel disease: analysis from the UK Medical Cannabis Registry3
The value of endoscopic ultrasonography for differential diagnosis in obstructive jaundice of the distal common bile duct3
Impact of diabetes mellitus on the long-term prognosis of patients with hepatocellular carcinoma after hepatectomy3
Targeting neutrophils in inflammatory bowel disease: revisiting the role of adsorptive granulocyte and monocyte apheresis3
Efficacy of rifaximin in treating with small intestine bacterial overgrowth: a systematic review and meta-analysis3
Validated approaches at mayo clinic for measuring gastric and colonic transit of solids and gastric accommodation3
An overview of the efficacy, safety, and predictors of achalasia treatments3
Diagnosing and managing gastroparesis - where are we now?3
Is oncolytic adenoviral-mediated immunotherapy through p53-overexpression the solution to refractory pancreatic ductal adenocarcinoma?3
Metabolic disorders and the risk of cholangiocarcinoma3
Current epidemiology in hepatocellular carcinoma3
Revolutionizing liver fibrosis research: the promise of 3D organoid models in understanding and treating chronic liver disease3
Novel approaches in the medical management of compensated cirrhosis3
Antibiotics in decompensated liver disease – who, when and for how long?3
Recommendations for the management of gastrointestinal comorbidities with or without trofinetide use in Rett syndrome3
Novel therapeutics to treat chronic pancreatitis: targeting pancreatic stellate cells and macrophages3
Sofosbuvir/velpatasvir for the treatment of hepatitis C in pediatric patients3
Toward personalized therapy for cholangiocarcinoma: new insights and challenges3
Identifying and managing rare subtypes of gastrointestinal stromal tumors3
Endoscopic ultrasound guided liver biopsy and portal pressure gradient: when, why and how? Can it become the standard of care in endo-hepatology?3
Electrosurgical unit in GI endoscopy: the proper settings for practice3
Antireflux surgeries and hiatal repair: keys to success3
Diagnosis of peritoneal tuberculosis by real-time immuno-PCR assay based on detection of a cocktail ofMycobacterium tuberculosisCFP-10 and HspX proteins3
Fluoropyrimidine-based doublet chemotherapy as second-line treatment for advanced biliary tract cancer: a meta-analysis of ABC-06 and NIFTY3
Mistakes in utilising histopathology for the management of liver disease3
Differences between current clinical guidelines for screening, diagnosis and management of nonalcoholic fatty liver disease and real-world practice: a targeted literature review3
Research progress on short-term prognosis of acute-on-chronic liver failure2
The necessity and safety of simultaneous cholecystectomy during gastric surgery for patients with asymptomatic cholelithiasis2
Pathophysiology and therapeutic management of anemia in gastrointestinal disorders2
Survival benefit of adjuvant transcatheter arterial chemoembolization for patients with hepatocellular carcinoma after anatomical hepatectomy2
Key factors for improving adenoma detection rate2
Overcoming the effects of increasing antimicrobial resistance on Helicobacter pylori therapy2
Same versus separate sessions of endoscopic ultrasound-guided fine-needle biopsy and endoscopic retrograde cholangiopancreatography for distal malignant biliary obstruction: a propensity score-matched2
Risk factors for recurrent common bile duct stones: a systematic review and meta-analysis2
Nonachalasic esophageal motor disorders, from diagnosis to therapy2
Serological testing for celiac disease in children2
A role for immune modulation in achieving functional cure for chronic hepatitis B among current changes in the landscape of new treatments2
What can real-world data teach us about treating patients with unresectable hepatocellular carcinoma?2
The role of videocapsule endoscopy in the diagnosis and follow-up of celiac disease: a scoping review2
The role of microRNAs on the pathogenesis, diagnosis and management of portal hypertension in patients with chronic liver disease2
Gastrointestinal reported outcomes following one anastomosis gastric bypass based on a multicenter study2
Achalasia, from diagnosis to treatment2
Intermediate hepatocellular carcinoma: new horizons and prospects for our patients2
Bone health in inflammatory bowel disease2
Clinical utility of clonal origin determination in managing recurrent hepatocellular carcinoma2
Therapeutics for Clostridioides difficile infection: molecules and microbes2
Risk factors associated with failure of endoscopic combined treatment to prevent varices rebleeding in patients with liver cirrhosis2
New progress with calcium-binding protein S100A16 in digestive system disease2
Hemostatic powders and gels in gastrointestinal endoscopy: current perspective and future recommendations2
Noninvasive identification of metabolic dysfunction–associated steatohepatitis (INFORM MASH): a retrospective cohort and disease modeling study2
Pneumatic dilation for the treatment of persistent post-laparoscopic fundoplication dysphagia: long-term efficacy and safety2
Endoscopic ultrasound-guided radiofrequency ablation of pancreatic insulinoma: a state of the art review2
Eosinophilic esophagitis in the era of biologics2
Current evidence on the therapeutic use of fiber in irritable bowel syndrome2
Histologic assessments in ulcerative colitis: the evidence behind a new endpoint in clinical trials2
A critical review of adalimumab for the treatment of moderate-to-severe active ulcerative colitis in children2
The association of fatty liver and risk of hepatocellular carcinoma in HBV or HCV infected individuals: a systematic review and meta-analysis2
Cellular senescence and its pathogenic and therapeutic implications in autoimmune hepatitis2
Unraveling the link: diagnosing metabolic dysfunction-associated steatotic liver disease in the context of decompensated cirrhosis2
Cirrhosis and non-hepatic surgery in 2023 – a precision medicine approach2
The use of personal protective equipment in endoscopy: what should the endoscopist wear during a pandemic?2
Response to letter: ‘Bayesian analysis and the role of local palliative therapeutics for malignant biliary obstruction’2
Algorithms for early detection of silent liver fibrosis in the primary care setting – a scoping review2
Dupilumab is efficacious for eosinophilic esophagitis irrespective of prior swallowed budesonide or fluticasone, or prior treatments used alongside swallowed topical corticosteroids: results from the 2
0.10083508491516